- Q1 2024 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 08, 2024$9.61 (+0.63%)Earnings
- Q4 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptFeb 28, 2024$5.35 (-3.78%)Earnings
- Mind Medicine (MindMed) Inc to Host Conference Call TranscriptDec 14, 2023
- Q3 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 02, 2023$2.7 (+8.43%)Earnings
- Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Q2 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 03, 2023$4.71 (+2.61%)Earnings
- Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference TranscriptJun 26, 2023
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Q1 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 04, 2023$3.62 (-1.90%)Earnings
- Mind Medicine (MindMed) Inc at ROTH Conference TranscriptMar 13, 2023
- Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 09, 2023$3.18 (-4.79%)Earnings
- Mind Medicine (MindMed) Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Mind Medicine (MindMed) Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 10, 2022$2.6 (+7.88%)Earnings
- Q2 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 11, 2022$9.75 (-0.21%)Earnings
- Mind Medicine (MindMed) Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- Q1 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 16, 2022$12.01 (+2.64%)Earnings
- Q4 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 28, 2022$17.4 (-1.69%)Earnings
- Q2 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 16, 2021Earnings
Mind Medicine (MindMed) Inc at Canaccord Genuity Growth Conference Transcript
(audio in progress) Barrow, the CEO of Mind Medicine. Mind Medicine or MindMed for short is a neuro-pharmaceutical company developing psychedelic-inspired medicines. Its clinical programs include the study of an ibogaine derivative for opioid withdrawal and addiction and the study of LSD for ADHD and anxiety, as well as pain.
Mr. Barrow joined MindMed as Chief Development Officer earlier this -- earlier last year. And few months later, he was promoted to CEO -- so very quickly -- briefly served as Director of Drug Development and Discovery at Usona Institute. And this is a not-for-profit. He was actually one of the early incumbents in the psychedelic research space. They were looking at psilocybin for depression, similar to many other companies in the space.
Now, Robert, I would like to invite you to join me up here on the podium to tell our investors a little bit about MindMed. I would like to remind everyone, please hold your questions for the end. We will give you five minutes to ask questions after the presentation.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)